Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Universität Regensburg currently manages 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 5 distinct art units, indicating a broad and diverse range of technical research being prosecuted simultaneously. The involvement of these examination groups highlights the complexity of managing this portfolio within the Biotechnology & Pharmaceuticals sector.
The portfolio is reviewed by 5 distinct examiners, matching the count of 5 pending office actions. KAUR, GURPREET is identified as the busiest examiner, although they are currently handling only 1 pending office action. This distribution suggests that no individual examiner has a dominant influence over the university's overall patent strategy.
Each matter likely requires a unique approach tailored to the specific standards and preferences of the 5 distinct examiners. Because the workload is spread across 5 distinct art units, practitioners must monitor a wide variety of examination trends to successfully navigate the filings currently active.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAUR, GURPREET | 1 | 65.2% | +35.9% |
| FLORES, ADRIAN | 1 | 100.0% | +0.0% |
| HURST, JONATHAN M | 1 | 53.6% | +18.7% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
| DEBERRY, REGINA M | 1 | 50.1% | +30.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691061 | CARBON NANOFIBER ELECTRODES FOR FLOW-THROUGH ELECTROCHEMICAL SENSORS | KAUR, GURPREET | — |
| 18288971 | DEVICE, TOOL AND SYSTEM FOR MINIMALLY INVASIVE ORBITAL FLOOR FRACTURE IMPLANTATION | FLORES, ADRIAN | — |
| 17781112 | VIRUS-MIMETIC NANOPARTICLES | DEBERRY, REGINA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17910239 | A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE | KWON, JOHN SEUNGJAI | 6d |
| 18691061 | CARBON NANOFIBER ELECTRODES FOR FLOW-THROUGH ELECTROCHEMICAL SENSORS | KAUR, GURPREET | — |
| 18042478 | DEVICE AND METHOD FOR DETECTING WATER FLOW THROUGH AT LEAST ONE LAYER OF BIOLOGICAL CELLS | HURST, JONATHAN M | — |
| 17781112 | VIRUS-MIMETIC NANOPARTICLES | DEBERRY, REGINA M | — |
| Art Unit | Apps |
|---|---|
| 1759 | 1 |
| 3774 | 1 |
| 2855 | 1 |
| 1615 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691061 | CARBON NANOFIBER ELECTRODES FOR FLOW-THROUGH ELECTROCHEMICAL SENSORS | KAUR, GURPREET | 1759 | §102§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18288971 | DEVICE, TOOL AND SYSTEM FOR MINIMALLY INVASIVE ORBITAL FLOOR FRACTURE IMPLANTATION | FLORES, ADRIAN | 3774 | §102§103 | Non-Final OA | — | Pending | Oct 30, 2023 |
| 18042478 | DEVICE AND METHOD FOR DETECTING WATER FLOW THROUGH AT LEAST ONE LAYER OF BIOLOGICAL CELLS | HURST, JONATHAN M | 2855 | §103 | Non-Final OA | — | Pending | Feb 22, 2023 |
| 17910239 | A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE | KWON, JOHN SEUNGJAI | 1615 | §103 | Final Rejection | 6d | Pending | Sep 08, 2022 |
| 17781112 | VIRUS-MIMETIC NANOPARTICLES | DEBERRY, REGINA M | 1647 | §102§103§112 | Final Rejection | — | Pending | May 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial